Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock

Area of Science:

• Immunology
• Critical Care Medicine
• Biochemistry

Background:

• Soluble glycoprotein sCD14 binds lipopolysaccharide (LPS), activating endothelial cells.
• This interaction is potentially crucial in the pathogenesis of gram-negative sepsis.
• Endothelial cell activation by LPS is a key event in septic shock.

Purpose of the Study:

• To investigate serum sCD14 levels in patients with gram-negative septic shock.
• To determine the prognostic value of sCD14 levels and its isoforms in septic shock.
• To compare sCD14 concentrations between septic shock patients and healthy controls.

Main Methods:

• Serum sCD14 was quantified using ELISA and Western blotting.
• Analysis included 54 patients with gram-negative septic shock and 26 healthy controls.
• Isoforms of sCD14 were identified in monocyte cultures and patient sera.

Main Results:

• Septic shock patients exhibited significantly higher serum sCD14 concentrations than controls (median, 3.23 vs. 2.48 µg/mL; P = .002).
• Elevated sCD14 levels were strongly associated with increased mortality (median, 4.2 µg/mL in nonsurvivors vs. 2.8 µg/mL in survivors; P = .001).
• While controls had the 49-kDa form, septic patients showed either 49- or 55-kDa forms; high sCD14 levels correlated with the 55-kDa form.

Conclusions:

• Serum sCD14 levels are significantly elevated in gram-negative septic shock.
• The concentration of sCD14, rather than its specific biochemical isoform, serves as a valuable prognostic indicator.
• Higher sCD14 levels are directly associated with increased mortality risk in gram-negative septic shock patients.